Researchers conducted a systematic literature review to examine the prevalence of and risk factors for multidrug resistant infections in patients with urinary tract infections.
while complicated UTIs involve underlying conditions or anatomical abnormalities requiring specialized care from urologists, infectious disease specialists, and other healthcare providers working ...
Medpage Today on MSN2 个月
FDA Approves Novel Treatment for UTIs
The treatment is not indicated for primary or step-down treatment of complicated UTI or complicated intra-abdominal ...
According to Report Ocean, the US Urinary Tract Infection (UTI) Therapeutics market is anticipated to grow at a CAGR of ~$% between 2022-2028 owing to rise in cases of UTIs, technological advancements ...
Fosfomycin disodium is under clinical development by Meitheal Pharmaceuticals and currently in Pre-Registration for Urinary Tract Infections.
[2] We recruited patients consecutively, and excluded from our material any patient that might be suspected to have any factors indicating a complicated UTI or an upper UTI. Our results should ...
While anyone experiencing UTI symptoms will benefit, the Biotia test is particularly helpful for patients with chronic recurring or complicated UTIs and those who are immunocompromised or who face ...